These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 32410111)

  • 1. MDA-9/Syntenin/SDCBP: new insights into a unique multifunctional scaffold protein.
    Pradhan AK; Maji S; Das SK; Emdad L; Sarkar D; Fisher PB
    Cancer Metastasis Rev; 2020 Sep; 39(3):769-781. PubMed ID: 32410111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MDA-9/Syntenin (SDCBP): Novel gene and therapeutic target for cancer metastasis.
    Das SK; Maji S; Wechman SL; Bhoopathi P; Pradhan AK; Talukdar S; Sarkar D; Landry J; Guo C; Wang XY; Cavenee WK; Emdad L; Fisher PB
    Pharmacol Res; 2020 May; 155():104695. PubMed ID: 32061839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockout of MDA-9/Syntenin (SDCBP) expression in the microenvironment dampens tumor-supporting inflammation and inhibits melanoma metastasis.
    Das SK; Guo C; Pradhan AK; Bhoopathi P; Talukdar S; Shen XN; Emdad L; Subler MA; Windle JJ; Sarkar D; Wang XY; Fisher PB
    Oncotarget; 2016 Jul; 7(30):46848-46861. PubMed ID: 27341128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mda-9/syntenin is expressed in uveal melanoma and correlates with metastatic progression.
    Gangemi R; Mirisola V; Barisione G; Fabbi M; Brizzolara A; Lanza F; Mosci C; Salvi S; Gualco M; Truini M; Angelini G; Boccardo S; Cilli M; Airoldi I; Queirolo P; Jager MJ; Daga A; Pfeffer U; Ferrini S
    PLoS One; 2012; 7(1):e29989. PubMed ID: 22267972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MDA-9/Syntenin: An emerging global molecular target regulating cancer invasion and metastasis.
    Das SK; Sarkar D; Emdad L; Fisher PB
    Adv Cancer Res; 2019; 144():137-191. PubMed ID: 31349898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDA-9/syntenin is essential for factor VIIa-induced signaling, migration, and metastasis in melanoma cells.
    Aissaoui H; Prévost C; Boucharaba A; Sanhadji K; Bordet JC; Négrier C; Boukerche H
    J Biol Chem; 2015 Feb; 290(6):3333-48. PubMed ID: 25505176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting tumor invasion: the roles of MDA-9/Syntenin.
    Kegelman TP; Das SK; Emdad L; Hu B; Menezes ME; Bhoopathi P; Wang XY; Pellecchia M; Sarkar D; Fisher PB
    Expert Opin Ther Targets; 2015 Jan; 19(1):97-112. PubMed ID: 25219541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The MDA-9/Syntenin/IGF1R/STAT3 Axis Directs Prostate Cancer Invasion.
    Das SK; Pradhan AK; Bhoopathi P; Talukdar S; Shen XN; Sarkar D; Emdad L; Fisher PB
    Cancer Res; 2018 Jun; 78(11):2852-2863. PubMed ID: 29572229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mda-9/Syntenin: a positive regulator of melanoma metastasis.
    Boukerche H; Su ZZ; Emdad L; Baril P; Balme B; Thomas L; Randolph A; Valerie K; Sarkar D; Fisher PB
    Cancer Res; 2005 Dec; 65(23):10901-11. PubMed ID: 16322237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of radiation-induced glioblastoma invasion by genetic and pharmacological targeting of MDA-9/Syntenin.
    Kegelman TP; Wu B; Das SK; Talukdar S; Beckta JM; Hu B; Emdad L; Valerie K; Sarkar D; Furnari FB; Cavenee WK; Wei J; Purves A; De SK; Pellecchia M; Fisher PB
    Proc Natl Acad Sci U S A; 2017 Jan; 114(2):370-375. PubMed ID: 28011764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the integrin effector kinase focal adhesion kinase in cancer cells is regulated by crosstalk between protein kinase Calpha and the PDZ adapter protein mda-9/Syntenin.
    Hwangbo C; Kim J; Lee JJ; Lee JH
    Cancer Res; 2010 Feb; 70(4):1645-55. PubMed ID: 20145126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mda-9/Syntenin: more than just a simple adapter protein when it comes to cancer metastasis.
    Sarkar D; Boukerche H; Su ZZ; Fisher PB
    Cancer Res; 2008 May; 68(9):3087-93. PubMed ID: 18451132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Src kinase activation is mandatory for MDA-9/syntenin-mediated activation of nuclear factor-kappaB.
    Boukerche H; Aissaoui H; Prévost C; Hirbec H; Das SK; Su ZZ; Sarkar D; Fisher PB
    Oncogene; 2010 May; 29(21):3054-66. PubMed ID: 20228839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MDA-9/syntenin and IGFBP-2 promote angiogenesis in human melanoma.
    Das SK; Bhutia SK; Azab B; Kegelman TP; Peachy L; Santhekadur PK; Dasgupta S; Dash R; Dent P; Grant S; Emdad L; Pellecchia M; Sarkar D; Fisher PB
    Cancer Res; 2013 Jan; 73(2):844-54. PubMed ID: 23233738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological inhibition of MDA-9/Syntenin blocks breast cancer metastasis through suppression of IL-1β.
    Pradhan AK; Maji S; Bhoopathi P; Talukdar S; Mannangatti P; Guo C; Wang XY; Cartagena LC; Idowu M; Landry JW; Sarkar D; Emdad L; Cavenee WK; Das SK; Fisher PB
    Proc Natl Acad Sci U S A; 2021 May; 118(21):. PubMed ID: 34016751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MDA-9/Syntenin-Slug transcriptional complex promote epithelial-mesenchymal transition and invasion/metastasis in lung adenocarcinoma.
    Wang LK; Pan SH; Chang YL; Hung PF; Kao SH; Wang WL; Lin CW; Yang SC; Liang CH; Wu CT; Hsiao TH; Hong TM; Yang PC
    Oncotarget; 2016 Jan; 7(1):386-401. PubMed ID: 26561205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MDA-9/Syntenin (SDCBP) modulates small GTPases RhoA and Cdc42 via transforming growth factor β1 to enhance epithelial-mesenchymal transition in breast cancer.
    Menezes ME; Shen XN; Das SK; Emdad L; Sarkar D; Fisher PB
    Oncotarget; 2016 Dec; 7(49):80175-80189. PubMed ID: 27863394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mda-9/Syntenin promotes metastasis in human melanoma cells by activating c-Src.
    Boukerche H; Su ZZ; Prévot C; Sarkar D; Fisher PB
    Proc Natl Acad Sci U S A; 2008 Oct; 105(41):15914-9. PubMed ID: 18832467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of Prostate Cancer Pathogenesis Using an MDA-9/Syntenin (SDCBP) PDZ1 Small-Molecule Inhibitor.
    Das SK; Kegelman TP; Pradhan AK; Shen XN; Bhoopathi P; Talukdar S; Maji S; Sarkar D; Emdad L; Fisher PB
    Mol Cancer Ther; 2019 Nov; 18(11):1997-2007. PubMed ID: 31345950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of protective autophagy in anoikis-resistant glioma stem cells by SDCBP/MDA-9/Syntenin.
    Talukdar S; Pradhan AK; Bhoopathi P; Shen XN; August LA; Windle JJ; Sarkar D; Furnari FB; Cavenee WK; Das SK; Emdad L; Fisher PB
    Autophagy; 2018; 14(10):1845-1846. PubMed ID: 30118375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.